Germline BRCA-mutated metastatic breast cancer with positive hormone receptor

Breast Cancer Res Treat. 2021 Feb;186(1):265-266. doi: 10.1007/s10549-020-06010-9. Epub 2020 Nov 10.

Authors

Michela Palleschi¹, Maria Laura Iaia¹, Chiara Casadei²

Affiliations

¹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via Piero Maroncelli 40, 47014, Meldola, Italy.
² Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via Piero Maroncelli 40, 47014, Meldola, Italy. chiara.casadei@irst.emr.it.

PMID: 33170437
DOI: 10.1007/s10549-020-06010-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal
Breast Neoplasms* / genetics
Female
Germ Cells
Hormones
Humans
Phthalazines
Piperazines

Substances

Antibodies, Monoclonal
Hormones
Phthalazines
Piperazines
durvalumab
olaparib